The changing role of economic evaluation in valuing medical technologies

Jason S. Rotter, Douglas Foerster, John FP Bridges

Research output: Contribution to journalArticle

Abstract

Economic evaluation is established within health-technology assessment but is challenged by those wanting to use economic evaluation to inform pricing and/or incorporate nontraditional sources of value and the views of diverse stakeholders. The changing role of economic evaluation in (formally or informally) assessing prices/values in four jurisdictions (UK, Australia, Germany and USA) is detailed and the authors propose a taxonomy of factors impacting the value of medical technology spanning clinical utility (effectiveness, safety/tolerability and quality of evidence), consumer demand (consumer preferences, process utility and unmet need), economic incentives (innovation, option value and market competition) and the societal perspective (social justice, social values and national interest). The authors suggest that multicriteria decision analysis methods grounded in hedonic-pricing theory can facilitate the valuing/pricing of medical technologies. The use of such an approach is hindered by a paucity of relevant educational opportunities, vested interests and aversion to placing prices/values on health.

Original languageEnglish (US)
Pages (from-to)711-723
Number of pages13
JournalExpert Review of Pharmacoeconomics and Outcomes Research
Volume12
Issue number6
DOIs
StatePublished - Dec 2012

Fingerprint

Cost-Benefit Analysis
Technology
Costs and Cost Analysis
Social Values
Biomedical Technology Assessment
Pleasure
Decision Support Techniques
Social Justice
Germany
Motivation
Economics
Safety
Health
Consumer Behavior

Keywords

  • economic evaluation
  • health-technology assessment
  • medical technologies
  • pricing
  • value

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Health Policy

Cite this

The changing role of economic evaluation in valuing medical technologies. / Rotter, Jason S.; Foerster, Douglas; Bridges, John FP.

In: Expert Review of Pharmacoeconomics and Outcomes Research, Vol. 12, No. 6, 12.2012, p. 711-723.

Research output: Contribution to journalArticle

Rotter, Jason S. ; Foerster, Douglas ; Bridges, John FP. / The changing role of economic evaluation in valuing medical technologies. In: Expert Review of Pharmacoeconomics and Outcomes Research. 2012 ; Vol. 12, No. 6. pp. 711-723.
@article{06dff8ba2dfe4dd0934ab8529e2cfe21,
title = "The changing role of economic evaluation in valuing medical technologies",
abstract = "Economic evaluation is established within health-technology assessment but is challenged by those wanting to use economic evaluation to inform pricing and/or incorporate nontraditional sources of value and the views of diverse stakeholders. The changing role of economic evaluation in (formally or informally) assessing prices/values in four jurisdictions (UK, Australia, Germany and USA) is detailed and the authors propose a taxonomy of factors impacting the value of medical technology spanning clinical utility (effectiveness, safety/tolerability and quality of evidence), consumer demand (consumer preferences, process utility and unmet need), economic incentives (innovation, option value and market competition) and the societal perspective (social justice, social values and national interest). The authors suggest that multicriteria decision analysis methods grounded in hedonic-pricing theory can facilitate the valuing/pricing of medical technologies. The use of such an approach is hindered by a paucity of relevant educational opportunities, vested interests and aversion to placing prices/values on health.",
keywords = "economic evaluation, health-technology assessment, medical technologies, pricing, value",
author = "Rotter, {Jason S.} and Douglas Foerster and Bridges, {John FP}",
year = "2012",
month = "12",
doi = "10.1586/erp.12.73",
language = "English (US)",
volume = "12",
pages = "711--723",
journal = "Expert Review of Pharmacoeconomics and Outcomes Research",
issn = "1473-7167",
publisher = "Expert Reviews Ltd.",
number = "6",

}

TY - JOUR

T1 - The changing role of economic evaluation in valuing medical technologies

AU - Rotter, Jason S.

AU - Foerster, Douglas

AU - Bridges, John FP

PY - 2012/12

Y1 - 2012/12

N2 - Economic evaluation is established within health-technology assessment but is challenged by those wanting to use economic evaluation to inform pricing and/or incorporate nontraditional sources of value and the views of diverse stakeholders. The changing role of economic evaluation in (formally or informally) assessing prices/values in four jurisdictions (UK, Australia, Germany and USA) is detailed and the authors propose a taxonomy of factors impacting the value of medical technology spanning clinical utility (effectiveness, safety/tolerability and quality of evidence), consumer demand (consumer preferences, process utility and unmet need), economic incentives (innovation, option value and market competition) and the societal perspective (social justice, social values and national interest). The authors suggest that multicriteria decision analysis methods grounded in hedonic-pricing theory can facilitate the valuing/pricing of medical technologies. The use of such an approach is hindered by a paucity of relevant educational opportunities, vested interests and aversion to placing prices/values on health.

AB - Economic evaluation is established within health-technology assessment but is challenged by those wanting to use economic evaluation to inform pricing and/or incorporate nontraditional sources of value and the views of diverse stakeholders. The changing role of economic evaluation in (formally or informally) assessing prices/values in four jurisdictions (UK, Australia, Germany and USA) is detailed and the authors propose a taxonomy of factors impacting the value of medical technology spanning clinical utility (effectiveness, safety/tolerability and quality of evidence), consumer demand (consumer preferences, process utility and unmet need), economic incentives (innovation, option value and market competition) and the societal perspective (social justice, social values and national interest). The authors suggest that multicriteria decision analysis methods grounded in hedonic-pricing theory can facilitate the valuing/pricing of medical technologies. The use of such an approach is hindered by a paucity of relevant educational opportunities, vested interests and aversion to placing prices/values on health.

KW - economic evaluation

KW - health-technology assessment

KW - medical technologies

KW - pricing

KW - value

UR - http://www.scopus.com/inward/record.url?scp=84871491409&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84871491409&partnerID=8YFLogxK

U2 - 10.1586/erp.12.73

DO - 10.1586/erp.12.73

M3 - Article

C2 - 23252354

AN - SCOPUS:84871491409

VL - 12

SP - 711

EP - 723

JO - Expert Review of Pharmacoeconomics and Outcomes Research

JF - Expert Review of Pharmacoeconomics and Outcomes Research

SN - 1473-7167

IS - 6

ER -